2017-11-20 09:07 Diamorph AB: Interim Report Third Quarter 2017 Third quarter In our previous second quarter report we noted the results should be considered against a strong […]
2017-11-14 09:31 Episurf Medical: Episealer® 24 months’ clinical study results accepted for publication in peer-reviewed scientific journal Episurf Medical (NASDAQ: EPIS B) today announces that a peer-reviewed article with clinical data on 10 Episealer® knee […]
2017-11-13 11:25 IRRAS announces initial public offering and publishes prospectus for listing on Nasdaq First North Premier The press release in its entirety and the prospectus can be found on the company’s homepage. Link to […]
2017-11-13 08:52 Xbrane Biopharma releases interim report for the period July to September 2017 Xbrane Biopharma ABs interim report for the period July – September 2017 is now available on the Company’s […]
2017-11-10 13:48 Episurf Medical’s CEO Pål Ryfors acquires shares corresponding to 3.2% of capital and 6.8% of votes from main shareholder Serendipity Ixora Episurf Medical’s (NASDAQ: EPIS B) CEO Pål Ryfors and the company’s largest shareholder Serendipity Ixora have today reached […]
2017-11-10 08:42 Episurf Medical: 5 years’ follow-up of the first Episealer® patient Episurf Medical (NASDAQ: EPIS B) announces that the first patient who received an Episealer® knee implant has been […]
2017-11-10 08:39 Episurf Medical to present clinical data at Stora Aktiedagen, Stockholm, on November 13 Episurf Medical (NASDAQ: EPIS B) will present clinical data at the event Stora Aktiedagen, Stockholm, on November 13. […]
2017-11-10 08:38 Episurf Medical: Interim Report 1 July - 30 September 2017 Third quarter 2017, compared to 2016, Group 50% growth in orders for Episealer® knee implants during the quarter […]
2017-11-09 10:10 Episurf Medical will exhibit at the 6th annual conference of the German Knee Society (DKG), held in Cologne, Germany, on November 24-26 Episurf Medical (NASDAQ: EPIS B) will exhibit at 6th annual conference of the German Knee Society (DKG), held […]
2017-11-09 10:08 Episurf Medical will exhibit at the Sports Knee conference 2017, held in Burton-on-Trent, UK, on November 20-21 Episurf Medical (NASDAQ: EPIS B) will exhibit at Sports Knee conference 2017, held in Burton-on-Trent, UK (St George’s […]
2017-11-09 10:07 Organoclick AB (publ) publishes its interim report for Q3 2017 “Our positive trend contnued during the third quarter with a total sales growth of 88 % and an […]
2017-10-31 10:15 Change in number of shares and votes in Episurf Medical On the behalf of shareholders in Episurf Medical AB (NASDAQ: EPIS B), conversions of class A shares to […]
2017-10-25 09:48 New patent in China for Episurf Medical Episurf Medical (NASDAQ: EPIS B) is obtaining another new patent in China. The Chinese Patent Office SIPO has […]
2017-10-10 07:59 Xbrane Biopharma AB appoints Dina Jurman, Head of Clinical Affairs, to management team Xbrane Biopharma AB (publ) has appointed Dina Jurman, Head of Clinical Affairs at Xbrane, to its management team. […]
2017-10-09 09:36 Episurf Medical will exhibit at the Norwegian Orthopaedic Society’s Autumn Meeting 2017, held in Oslo, Norway, on October 25-27 Episurf Medical (NASDAQ: EPIS B) will exhibit at the Norwegian Orthopaedic Society’s Autumn Meeting 2017, held in Oslo, […]
2017-10-09 09:32 Episurf Medical will exhibit at the Danish Orthopaedic Society’s Congress 2017, held in Copenhagen, Denmark, on October 26-28 Episurf Medical (NASDAQ: EPIS B) will exhibit at the Danish Orthopaedic Society’s Congress 2017, held in Copenhagen, Denmark […]
2017-10-06 07:12 Members of the Nomination Committee for Episurf Medical's Annual General Meeting in 2018 In accordance with decision by the Annual General Meeting, Episurf Medical’s Nomination Committee shall consist of four members. […]
2017-09-26 14:40 Serendipity founders Ashkan Pouya and Saeid Esmaeilzadeh featured in Nordic Life Science Magazine Extract from article: Being a successful entrepreneur in the life sciences requires the same skills as any entrepreneur, […]
2017-09-22 08:28 Episurf Medical will exhibit at the Combined Bristol & Oxford Unicompartmental Knee Arthritis Symposium, held in Oxford, UK, on October 10 Episurf Medical (NASDAQ: EPIS B) will exhibit at the Combined Bristol & Oxford Unicompartmental Knee Arthritis Symposium held […]
2017-09-21 12:20 Xbrane Biopharma AB: Xbrane attends Carnegie Nordic HealthCare Day in New York, 5 December Xbrane is pleased to announce its participation in Carnegie Nordic Healthcare Day in New York in collaboration with […]
2017-09-20 07:30 Organoclick resolves upon a directed share issue of approximately SEK 40 million for financing of acquisitions and continued growth NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, […]
2017-09-19 17:31 Organoclick intends to undertake a directed share issue for financing potential acquisitions and the company's continued growth At large demand, Serendipity Ixora may make shares available to enable greater institutional participation NOT FOR PUBLICATION, DISTRIBUTION […]
2017-09-14 09:15 Episurf Medical’s 100th Episealer® Femoral Twin implant demonstrates rapid clinical adoption Episurf Medical (NASDAQ: EPIS B) announces the 100th implantation of the knee implant Episealer Femoral Twin, which together […]
2017-09-13 16:06 IRRAS Strengthens Executive and Commercial Teams with Appointments of Karl-Matthias Moehlmann and Klemens Fölling LA JOLLA, Calif., LAICHINGEN, Germany and STOCKHOLM, Sept. 13, 2017 IRRAS, a commercial-stage medical technology company developing breakthrough […]
2017-09-11 07:36 Episurf Medical AB will exhibit at The Individualized TKA, held in Antwerp, Belgium, on September 22 Episurf Medical (NASDAQ: EPIS B) will exhibit at The Individualized TKA (a meeting organized by the Belgian and […]
2017-09-11 07:35 Episurf Medical AB will exhibit at the London Knee Meeting held in London, UK, on October 3 Episurf Medical (NASDAQ: EPIS B) will exhibit at the London Knee Meeting (recognized as one of the most […]
2017-09-11 07:34 Xbrane confirms order of Spherotide to value of SEK 8.5 million and more than 10,000 doses sold Xbrane has confirmed an additional order of Spherotide from Pooyesh Darou, its partner in the Middle East, to […]
2017-09-07 07:14 Episurf Medical present at Aktiedagen, held in Malmö on September 27 Episurf Medical (NASDAQ: EPIS B) will present at Aktiedagen, an investor conference held in Malmö (Kockum Fritid, Hörsalen) […]
2017-09-07 07:13 Episurf Medical AB will exhibit at FISIC’17 held in London, UK, on September 27-28 Episurf Medical (NASDAQ: EPIS B) will exhibit at FISIC’17 (organised by renowned Fortius Group, UK’s leading private orthopaedic […]
2017-09-06 07:29 100 patient multi-center study of the Episealer® knee implant fully recruited Episurf Medical (NASDAQ: EPIS B) today announces that a European large multi-center study with 100 Episealer patients has […]
